News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
155,288 Results
Type
Article (8569)
Company Profile (42)
Press Release (146673)
Multimedia
Podcasts (12)
Webinars (4)
Section
Business (45639)
Career Advice (143)
Deals (8010)
Drug Delivery (33)
Drug Development (20792)
Employer Resources (12)
FDA (4474)
Job Trends (2714)
News (80530)
Policy (9020)
Tag
Academia (503)
Accelerated approval (8)
Adcomms (7)
Allergies (41)
Alliances (15742)
ALS (31)
Alzheimer's disease (383)
Antibody-drug conjugate (ADC) (70)
Approvals (4474)
Artificial intelligence (86)
Autoimmune disease (16)
Automation (7)
Bankruptcy (28)
Best Places to Work (2190)
BIOSECURE Act (16)
Biosimilars (109)
Biotechnology (33)
Bladder cancer (47)
Brain cancer (8)
Breast cancer (91)
Cancer (956)
Cardiovascular disease (50)
Career advice (125)
Career pathing (3)
CAR-T (41)
CDC (9)
Cell therapy (157)
Cervical cancer (6)
Clinical research (17710)
Collaboration (409)
Compensation (93)
Complete response letters (19)
COVID-19 (713)
CRISPR (9)
C-suite (125)
Cystic fibrosis (18)
Data (1072)
Denatured (3)
Depression (17)
Diabetes (63)
Diagnostics (1132)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (57)
Drug pricing (37)
Drug shortages (1)
Duchenne muscular dystrophy (70)
Earnings (16395)
Editorial (11)
Employer branding (3)
Employer resources (10)
Events (18372)
Executive appointments (199)
FDA (5212)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (273)
Gene editing (34)
Generative AI (8)
Gene therapy (147)
GLP-1 (171)
Government (1517)
Grass and pollen (2)
Guidances (93)
Healthcare (2896)
HIV (10)
Huntington's disease (7)
IgA nephropathy (13)
Immunology and inflammation (78)
Immuno-oncology (6)
Indications (18)
Infectious disease (772)
Inflammatory bowel disease (66)
Inflation Reduction Act (6)
Influenza (30)
Intellectual property (42)
Interviews (11)
IPO (3226)
IRA (16)
Job creations (605)
Job search strategy (121)
Kidney cancer (3)
Labor market (6)
Layoffs (69)
Leadership (1)
Legal (1453)
Liver cancer (29)
Longevity (6)
Lung cancer (162)
Lymphoma (71)
Machine learning (6)
Management (2)
Manufacturing (224)
MASH (32)
Medical device (2211)
Medtech (2216)
Mergers & acquisitions (5030)
Metabolic disorders (173)
Multiple sclerosis (29)
NASH (3)
Neurodegenerative disease (36)
Neuropsychiatric disorders (1)
Neuroscience (567)
NextGen: Class of 2025 (897)
Non-profit (414)
Now hiring (12)
Obesity (67)
Opinion (56)
Ovarian cancer (47)
Pain (18)
Pancreatic cancer (33)
Parkinson's disease (42)
Partnered (6)
Patents (81)
Patient recruitment (66)
Peanut (23)
People (12399)
Pharmaceutical (13)
Pharmacy benefit managers (4)
Phase I (5477)
Phase II (7421)
Phase III (6483)
Pipeline (822)
Policy (97)
Postmarket research (515)
Preclinical (2100)
Press Release (66)
Prostate cancer (42)
Psychedelics (6)
Radiopharmaceuticals (61)
Rare diseases (153)
Real estate (1416)
Recruiting (4)
Regulatory (7185)
Reports (12)
Research institute (466)
Resumes & cover letters (12)
Rett syndrome (1)
RNA editing (3)
RSV (17)
Schizophrenia (26)
Series A (56)
Series B (29)
Service/supplier (4)
Sickle cell disease (16)
Special edition (4)
Spinal muscular atrophy (25)
Sponsored (12)
Startups (942)
State (1)
Stomach cancer (5)
Supply chain (19)
Tariffs (17)
The Weekly (9)
Vaccines (271)
Venture capital (12)
Weight loss (25)
Women's health (5)
Date
Today (40)
Last 7 days (122)
Last 30 days (593)
Last 365 days (8032)
2025 (5762)
2024 (8906)
2023 (9902)
2022 (14512)
2021 (14559)
2020 (13047)
2019 (9072)
2018 (7026)
2017 (8087)
2016 (7297)
2015 (8785)
2014 (6389)
2013 (5138)
2012 (5445)
2011 (5710)
2010 (4996)
Location
Africa (165)
Alabama (19)
Alaska (1)
Arizona (24)
Arkansas (2)
Asia (25682)
Australia (3080)
California (2068)
Canada (579)
China (436)
Colorado (42)
Connecticut (54)
Delaware (75)
Europe (24773)
Florida (253)
Georgia (40)
Idaho (13)
Illinois (89)
India (26)
Indiana (53)
Iowa (7)
Japan (162)
Kansas (9)
Kentucky (11)
Louisiana (3)
Maine (9)
Maryland (447)
Massachusetts (1454)
Michigan (32)
Minnesota (89)
Mississippi (2)
Missouri (22)
Montana (5)
Nebraska (2)
Nevada (10)
New Hampshire (3)
New Jersey (825)
New Mexico (4)
New York (566)
North Carolina (300)
North Dakota (9)
Northern California (889)
Ohio (50)
Oklahoma (9)
Oregon (5)
Pennsylvania (323)
Puerto Rico (1)
Rhode Island (6)
South America (229)
South Carolina (3)
Southern California (897)
Tennessee (4)
Texas (263)
United States (7233)
Utah (46)
Virginia (58)
Washington D.C. (9)
Washington State (153)
West Virginia (1)
Wisconsin (16)
155,288 Results for "cobra biologics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
Press Releases
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
August 28, 2025
·
5 min read
FDA
After Prasad’s Ouster, Makary Looks for Better Drug, Biologic Alignment at FDA
The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research into one entity.
August 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Investor Conferences in September 2025
August 25, 2025
·
1 min read
Press Releases
Ayrmid Ltd. Announces FDA Acceptance and Priority Review for Omidubicel for the Treatment of Severe Aplastic Anemia (SAA)
August 25, 2025
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results
August 19, 2025
·
2 min read
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to share additional data from its diagnostic 64Cu-SAR-bisPSMA trial, COBRA.
March 8, 2024
·
11 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
·
3 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Binding Supply and Development Agreement with Holista Colltech Ltd.
September 4, 2025
·
3 min read
Press Releases
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
September 15, 2025
·
5 min read
1 of 15,529
Next
